APPLICATION OF NEW METHODOLOGY TO ALLOW COMPARISON OF DURATION OF RESPONSE AND DURATION OF CLINICAL BENEFIT BETWEEN FULVESTRANT TREATMENT GROUPS IN THE CONFIRM TRIAL

被引：0

作者：

Garnett, Sally ^{[1
]}

Martin, Miguel ^{[2
]}

Jerusalem, Guy ^{[3
]}

Petruzelka, Lubos ^{[4
]}

Torres, Roberto ^{[5
]}

Bondarenko, Igor N. ^{[6
]}

Khasanov, Rustem ^{[7
]}

Verhoeven, Didier ^{[8
]}

Pedrini, Jose L. ^{[9
]}

Smirnova, Iya ^{[10
]}

Lichinitser, Mikhail R. ^{[11
]}

Pendergrass, Kelly ^{[12
]}

Lindemann, Justin P. O. ^{[1
]}

Di Leo, Angelo ^{[13
]}

机构：

[1] AstraZeneca, Macclesfield, Cheshire, England

[2] Hosp Univ Gregorio Maranon, Madrid, Spain

[3] CHU Sart Tilman, B-4000 Liege, Belgium

[4] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[5] Inst Nacl Canc, Santiago, Chile

[6] Dnipropetrovsk Municipal Clin Hosp, Dnepropetrovsk, Ukraine

[7] Republican Clin Oncol Ctr, Kazan, Russia

[8] AZ Klina, Brasschaat, Belgium

[9] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil

[10] Med Radiol Sci Ctr, Obninsk, Russia

[11] Russian Canc Res Ctr, Moscow, Russia

[12] Kansas City Canc Ctr, Kansas City, KS USA

[13] Hosp Prato, Prato, Italy

来源：

BREAST | 2011年 / 20卷

关键词：

D O I：

10.1016/j.breast.2011.08.098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S45 / S45

页数：1

共 22 条